## Consolidated Statement of Equity

**Year Ended**

|  | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 |
| --- | --- | --- | --- |
|       Total Stockholders' Equity - Beginning balance | 102,330 | 82,718 | 82,718 |
| *        Common stock and paid-in capital* | 80,552 | 78,520 | 71,223 |
| *        Cumulative effect of accounting changes - Retained earnings* |  | 677 | (42) |
| *        Retained earnings* | 34,566 | 24,150 | 13,682 |
| *        Cumulative effect of accounting changes - Accumulated other comprehensive income (loss)* |  | (67) | 42 |
| *        Accumulated other comprehensive income (loss)* | 3,186 | (340) | (2,187) |
| *        Derivatives* | (38) |  | 173 |
| *        Cumulative effect of accounting changes - Investments* |  | (67) | 42 |
| *        Investments* | 5,478 | 1,488 | (850) |
| *        Translation adjustments and other* | (2,254) | (1,828) | (1,510) |
|       Accounting Standards Update [Extensible List] | us-gaap:AccountingStandardsUpdate201601Member | us-gaap:AccountingStandardsUpdate201601Member | us-gaap:AccountingStandardsUpdate201601Member |
|       Common stock issued - Beginning balance |  |  |  |
| *        Common stock and paid-in capital - Ending balance* | 1,343 | 6,829 | 1,002 |
|       Net Income - Beginning balance | 44,281 | 39,240 | 16,571 |
| *        Retained earnings - Ending balance* | 44,281 | 39,240 | 16,571 |
|       Other comprehensive income (loss) - Beginning balance | 3,526 | 1,914 | (2,856) |
| *        Accumulated other comprehensive income (loss)* | 3,526 | 1,914 | (2,856) |
| *        Derivatives* | (38) | (173) | 39 |
| *        Investments* | 3,990 | 2,405 | (2,717) |
| *        Translation adjustments and other - Ending balance* | (426) | (318) | (178) |
|       Common stock cash dividends - Beginning balance | 15,488 | 14,101 |  |
| *        Retained earnings - Ending balance* | 15,483 | 14,103 | 12,917 |
|       Common stock repurchased - Beginning balance |  |  |  |
| *        Common stock and paid-in capital* | 4,599 | 4,195 | 3,033 |
| *        Retained earnings* | 18,382 | 15,346 | 7,699 |
| *        Share Repurchase Programs 2016 and 2019* | 19,688 |  |  |
| *        Share Repurchase Program 2016* |  | 16,799 | 8,600 |
| *        Share Repurchase Program 2019 - Ending balance* |  |  |  |
|       Stock-based compensation expense - Beginning balance |  |  |  |
| *        Common stock and paid-in capital - Ending balance* | 5,289 | 4,652 | 3,940 |
|       Other, net - Beginning balance |  |  |  |
| *        Common stock and paid-in capital - Ending balance* | 1 | (11) | 1 |
|       Total Stockholders' Equity | 118,304 | 102,330 | 82,718 |
| *        Common stock and paid-in capital* | 80,552 | 78,520 | 71,223 |
| *        Cumulative effect of accounting changes - Retained earnings* |  | 677 | (42) |
| *        Retained earnings* | 34,566 | 24,150 | 13,682 |
| *        Cumulative effect of accounting changes - Accumulated other comprehensive income (loss)* |  | (67) | 42 |
| *        Accumulated other comprehensive income (loss)* | 3,186 | (340) | (2,187) |
| *        Derivatives* | (38) |  | 173 |
| *        Cumulative effect of accounting changes - Investments* |  | (67) | 42 |
| *        Investments* | 5,478 | 1,488 | (850) |
| *        Translation adjustments and other - Ending balance* | (2,254) | (1,828) | (1,510) |
|       Cash dividends declared per common share | 2.04 | 1.84 | 1.68 |